Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Morrison

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Psychopharmacology|April 3, 2018
The antipsychotic landscape: dopamine and beyondPaul D Morrison, Robin M Murray
Expert Review of Neurotherapeutics|December 26, 2006
Schizophrenia: more evidence for less glutamatePaul D Morrison, Lyn S Pilowsky
Current Biology : CB|December 20, 2005
SchizophreniaPaul D Morrison, Robin M Murray
Dialogues in Clinical Neuroscience|November 9, 2020
Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
Paul D Morrison, Robin M Murray
Schizophrenia Bulletin|June 3, 2009
From real-world events to psychosis: the emerging neuropharmacology of delusionsPaul D Morrison, R M Murray
Journal of Psychopharmacology (Oxford, England)|February 13, 2025
The mechanism of action of clozapinePaul D Morrison, Sameer Jauhar, Allan H Young
Current Pharmaceutical Design|June 22, 2012
Cannabis in the arm: what can we learn from intravenous cannabinoid studies?Amir Englund, James M Stone, Paul D Morrison
The British Journal of Psychiatry : the Journal of Mental Science|March 2, 2002
Fear knot. Neurobiological disruption of long-term fear memoryPaul D Morrison, Judith Allardyce, Joseph P McKane
BMC Complementary and Alternative Medicine|December 17, 2014
Analysis of the volatile organic compounds from leaves, flower spikes, and nectar of Australian grown Agastache rugosaHanaa Yamani, Nitin Mantri, Paul D Morrison, et al.
Journal of Psychopharmacology (Oxford, England)|January 30, 2007
Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective reviewJames M Stone, Paul D Morrison, Lyn S Pilowsky
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Psychopharmacology|April 3, 2018
The antipsychotic landscape: dopamine and beyondPaul D Morrison, Robin M Murray
Expert Review of Neurotherapeutics|December 26, 2006
Schizophrenia: more evidence for less glutamatePaul D Morrison, Lyn S Pilowsky
Current Biology : CB|December 20, 2005
SchizophreniaPaul D Morrison, Robin M Murray
Dialogues in Clinical Neuroscience|November 9, 2020
Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
Paul D Morrison, Robin M Murray
Schizophrenia Bulletin|June 3, 2009
From real-world events to psychosis: the emerging neuropharmacology of delusionsPaul D Morrison, R M Murray
Journal of Psychopharmacology (Oxford, England)|February 13, 2025
The mechanism of action of clozapinePaul D Morrison, Sameer Jauhar, Allan H Young
Current Pharmaceutical Design|June 22, 2012
Cannabis in the arm: what can we learn from intravenous cannabinoid studies?Amir Englund, James M Stone, Paul D Morrison
The British Journal of Psychiatry : the Journal of Mental Science|March 2, 2002
Fear knot. Neurobiological disruption of long-term fear memoryPaul D Morrison, Judith Allardyce, Joseph P McKane
BMC Complementary and Alternative Medicine|December 17, 2014
Analysis of the volatile organic compounds from leaves, flower spikes, and nectar of Australian grown Agastache rugosaHanaa Yamani, Nitin Mantri, Paul D Morrison, et al.
Journal of Psychopharmacology (Oxford, England)|January 30, 2007
Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective reviewJames M Stone, Paul D Morrison, Lyn S Pilowsky
Pageof 8